SCHEMBL1667425

SCHEMBL1667425

COC(=O)c1ccnc2nc(C)[nH]c12

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 1/20 0.44
GSK3B P49841 5/20 0.42
GSK3A P49840 1/20 0.42
KDM4E B2RXH2 2/20 0.41
GLA P06280 2/20 0.41
GAA P10253 2/20 0.41
MAPT P10636 1/20 0.41
ALDH1A1 P00352 1/20 0.41
PSMD14 O00487 1/20 0.40
MAP2K1 Q02750 1/20 0.40
PKN1 Q16512 1/20 0.40
PKN2 Q16513 1/20 0.40
DYRK1A Q13627 1/20 0.40
PBK Q96KB5 1/20 0.38
ATR Q13535 1/20 0.38
NUDT1 P36639 1/20 0.38
LMNA P02545 1/20 0.37
NR4A2 P43354 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18226346 0.85 NUDT1 (0.42) KDM5AGSK3BGSK3AKDM4EGLA
SCHEMBL1665551 0.82 KDM5B (0.47) KDM5A
SCHEMBL8231782 0.80 PBK (0.61) KDM5AGSK3BPBK
SCHEMBL18224937 0.80 GSK3B (0.43) KDM5AGSK3BGSK3AMAP2K1PKN1
SCHEMBL18225328 0.79 KDM4E (0.50) KDM5AGSK3BGSK3AKDM4EALDH1A1
SCHEMBL18224878 0.76 PBK (0.61) GSK3BPBK
SCHEMBL18225106 0.76 PBK (0.50) KDM4EGLAGAAALDH1A1MAP2K1
SCHEMBL8231388 0.76 PBK (0.58) GSK3BGSK3APBK
SCHEMBL12109510 0.75 KDM4E (0.46) KDM5AKDM4EGAAMAPTALDH1A1
SCHEMBL8241185 0.75 PBK (0.59) GSK3BPBK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1891042-B1 2-OXO-1-PYRROLIDINE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB PHARMA SA (BE) 2013-10-02 EP disclosed
EP-2308867-A2 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses UCB Pharma S.A. (BE) 2011-04-13 EP disclosed
EP-2308870-A2 2-oxo-1-pyrrolidine deriatives, processes for preparing them and their uses UCB Pharma S.A. (BE) 2011-04-13 EP disclosed